NEXT AIR BIOTREAT

Developing the next generation air treatment based on replacing non-renewable resources by microbiology

 Coordinatore UNIVERSITAT DE VALENCIA 

 Organization address address: AVENIDA BLASCO IBANEZ 13
city: VALENCIA
postcode: 46010

contact info
Titolo: Ms.
Nome: Angeles
Cognome: Sanchis
Email: send email
Telefono: +34 96 3983621
Fax: +34 96 3937729

 Nazionalità Coordinatore Spain [ES]
 Sito del progetto http://www.nextairbiotreat.eu/
 Totale costo 1˙051˙433 €
 EC contributo 1˙051˙433 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2011-IAPP
 Funding Scheme MC-IAPP
 Anno di inizio 2011
 Periodo (anno-mese-giorno) 2011-10-01   -   2015-09-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    UNIVERSITAT DE VALENCIA

 Organization address address: AVENIDA BLASCO IBANEZ 13
city: VALENCIA
postcode: 46010

contact info
Titolo: Ms.
Nome: Angeles
Cognome: Sanchis
Email: send email
Telefono: +34 96 3983621
Fax: +34 96 3937729

ES (VALENCIA) coordinator 447˙463.00
2    PAS SOLUTIONS BV

 Organization address address: LEGGELOO 31 A
city: DWINGELOO
postcode: 7991 PW

contact info
Titolo: Mr.
Nome: Andre
Cognome: Schoonhoven
Email: send email
Telefono: +31 521 520682

NL (DWINGELOO) participant 499˙724.00
3    EXEL COMPOSITES NV

 Organization address address: INDUSTRIEPARK DE BRUWAAN 2
city: OUDENAARDE
postcode: 9700

contact info
Titolo: Ms.
Nome: Katrien
Cognome: Delbaere
Email: send email
Telefono: +32 55 333041
Fax: +32 55333040

BE (OUDENAARDE) participant 104˙246.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

pas    emissions    removal    styrene    voc    reduce    emission    solutions    biological    exel    air    vocs    company    treatment    biotechnology   

 Obiettivo del progetto (Objective)

'Concerning the objective to reduce VOC emission as cost-effectively and environmentally-friendly as reasonably possible, biological air treatment has the potential to be Best Available Technology (BAT). This is valid not only for a large number of European companies with VOC emissions, but also for the European Union itself. In comparison with conventional technologies biological VOC treatment is economically beneficial, it contributes to a lower ecological footprint and implies a reduction of CO2, thus adding value to the EU policy to reduce VOC emissions as well as its objective to minimise the impact of climate change.

To achieve our aim, the three partners will share their knowledge and expertise. The Environmental Engineering group of the Spanish Universitat de València looks to advance the scientific knowledge of the complex mechanisms and processes occurring in the biological system. PAS Solutions, a Dutch SME company orientated to develop innovative solutions in air biotreatment, is the first worldwide company with a novel biotechnology running as end-of-pipe treatment in six European facilities. PAS strives to enhance and broaden the application of the technology. Exel Composites NV is a Belgian facility leader on composite manufacturing. EXEL, as problem owner, explores biotechnology for air emission control to generate lasting knowledge about styrene emission treatment within the company.

Our goal will be achieved by pursuing the following objectives with three overlapping research and partnership programme areas: • Development of a hybrid biotechnology for removal of hydrophilic VOCs. • Development of a peak shaving biotechnology for removal of styrene. • Development of a responsive control system.'

Introduzione (Teaser)

Volatile organic compounds (VOCs) such as benzene and styrene can be hazardous to our health as well as the environment. EU-funded researchers are working on removing VOCs from industrial air emissions with the use of biotechnology.

Altri progetti dello stesso programma (FP7-PEOPLE)

G-ETI (2014)

The Governance of Energy Technology Innovation: Investigating Regulatory Regimes in Shale Gas

Read More  

PI3KS IN DCS (2009)

The role of the phosphoinositide 3-kinases in the regulation of dendritic cells functions

Read More  

IMPROVINGADHERENCE (2012)

Improving medical treatment adherence : taking into account patients' perception of uncertainty in the causal relationship between their adherence behaviour and their health condition

Read More